UCLA biotech spin-out ImmunGene receives $9m from life sciences investor Ally Bridge Group.

Ophthalmic device company has closed a $4m series A round to further develop its STARflo device, an implant for glaucoma, preparation for a US launch.

Technical University of Munich spin-out ImevaX partners with Project Pharmaceuticals on stomach pain.

Pharmaceutical company Celgene Corporation is collaborating with Versant Ventures' biotech incubator Blueline Bioscience to develop biotech startups in Toronto, Canada.

Gary Fingerhut has officially become the executive director of Cleveland Clinic Innovations

Diagnostics company Oxford Immunotec, backed by Dow Chemical Company and Kaiser Permanente Ventures, raises $62.8m in IPO.

Language technology developer Fluential has closed its first round of funding at $8m following a $2m investment from NantWorks.